SEARCH

SEARCH BY CITATION

References

  • 1
    Malebranche R, Arnoux E, Guerin JM, Pierre GD, Laroche AR, Pean-Guichard C, Elie R, Morisset PH, Spira T, Mandeville R, Drotman P, Seemayer T, Dupuy J-M. Acquired immunodeficiency syndrome with severe gastrointestinal manifestations in Haiti. Lancet 1983;2:8738.
  • 2
    Wasserman P, Segal-Maurer S, Rubin D. Significant prevalence of wasting syndrome among women on HAART 1997–2002 documented by bio-electrical impedance analysis. Antivir Ther 2002;7:L66.
  • 3
    Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;31:8035.
  • 4
    [No authors listed]. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:119.
  • 5
    Croxson TS, Chapman WE, Miller LK, Levit CD, Senie R, Zumoff B. Changes in the hypothalamic-pituitary–gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab 1989;68:31721.
  • 6
    Dobs A, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988;84:6116.
  • 7
    Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996;81:40518.
  • 8
    Roulet V, Satie A-P, Ruffault A, Tortorec AL, Denis H, Guist'hau O, Patard J-J, Rioux-Leclerq N, Gicquel J, Jégou B, Dejucq-Rainsford N. Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. Am J Pathol 2006;169:2094103.
  • 9
    Reitschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis 2000;31:12404.
  • 10
    Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G. The effects of testosterone replacement with a nongenital, transdermal system, androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 1998;83:315562.
  • 11
    Grinspoon S, Corcoran C, Anderson E, Hubbard J, Stanley T, Basgoz N, Klibanski A. Sustained anabolic effects of long term androgen administration in men with AIDS wasting. Clin Infect Dis 1999;28:6346.
  • 12
    Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: A randomized controlled trial. JAMA 1999;281:128290.
  • 13
    From the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:248697.
  • 14
    Kahn SM, Hryb DJ, Nakhala AM, Romas NA, Rosner W. Beyond carrier proteins: Sex hormone binding globulin is synthesized in target cells. J Endocrinol 2002;175:11320.
  • 15
    Hryb DJ, Nakhala AM, Kahn SM, St George J, Levy NC, Romas NA, Rosner W. Sex hormone binding globulin in the prostate is locally synthesized and may act as an autocrine/paracrine effector. J Biol Chem 2002;277:2661822.
  • 16
    Plymate SR, Leonard JM, Paulsen CA, Fariss BL, Karpas AE. Sex hormone-binding globulin changes with androgen replacement. J Clin Endocrinol Metab 1983;57:6458.
  • 17
    Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991;72:839.
  • 18
    Gray A, Feldman HA, Mc Kinley JB, Longcope C. Age, disease, and changing sex hormone levels in middle aged men: Results of the Massachusetts male aging study. J Clin Endocrinol Metab 1991;75:101625.
  • 19
    Lapidus L, Lindstedt G, Lundberg P-A, Bengtsson C, Gredmark T. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 1986;32:14652.
  • 20
    Pascal N, Santa Amouzou EK, Sanni A, Namour F, Abdelmouttaleb I, Vidailhet M, Guéant J-L. Serum concentrations of sex hormone-binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus. Am J Clin Nutr 2002;76:23944.
  • 21
    De Moor P, Heyns W, Bouillon R. Growth hormone and the steroid binding β-globulin of human plasma. J Steroid Biochem 1972;3:593600.
  • 22
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women. J Endocrinol Invest 1996;19:53541.
  • 23
    Lamba H, Goldmeier D, Mackie NE, et al. Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. Int J STD AIDS 2004;15:2347.
  • 24
    Hausler G, Schmitt K, Blumel P, Plochl E, Waldhor TH, Frisch H. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with turners syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. J Clin Endocrinol Metab 1996;81:53641.
  • 25
    Malhorta A, Poon E, Tse WY, Pringle PJ, Hindmarsh PC, Brook CG. The effects of oxandrolone on the growth hormone gonadal axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf) 1993;38:3938.
  • 26
    Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S. Oxandrolone in the treatment of HIV-associated weight loss in men. J Acquir Immune Defic Syndr 2006;41:30414.
  • 27
    Martin ME, Benassayag C, Amiel C, Canton P, Nunez EA. Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+ patients. J Endocrinol Invest 1992;8:597603.
  • 28
    Lambert M, Zech F, De Nayer P, Jamez J, Vandercam B. Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection. Am J Med 1990;89:74851.
  • 29
    Poretsky L, Can S, Zumoff B. Testicular dysfunction in human immunodeficiency virus-infected men. Metabolism 1995;44:94653.
  • 30
    Sellmeyer DE, Grunfeld C, Schambelan M. Endocrine abnormalities associated with HIV infection and AIDS. In: MeriganT, BartlettJG, BolognesiD, eds. Textbook of AIDS medicine. 2nd edition. New York: Williams & Wilkins; 1999.
  • 31
    Holst J, Cajander S, Carlstrom K, Damber MG, Von Schoultz B. A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy. Br J Obstet Gynaecol 1983;90:35560.
  • 32
    Conway AJ, Boylan LM, Howe C, Ross G, Handelsman DJ. Randomized clinical trial of testosterone replacement therapy in hypogonadal men. Int J Androl 1988;11:24764.
  • 33
    Von Schoultz B, Carlstrom K. On the regulation of sex hormone-binding globulin, a challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem 1989;32:32734.
  • 34
    Yassin AA, Saad F. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med 2007;4:497501.
  • 35
    Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006;3:382407.
  • 36
    Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988;240:32730.
  • 37
    Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: A randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab 2007;92:56370.